NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Olivia Barr
Cornell University - Ithaca / United States
Medical and Health Sciences / Neuroscience
AD Scientific Index ID: 5321273
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Olivia Barr's MOST POPULAR ARTICLES
1-)
Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptideCE Plummer, T Polk, J Sharma, SS Bae, O Barr, A Jones, H Kitchen, ...Scientific reports 12 (1), 7177, 202272022
2-)
Accelerating the in vitro emulation of Alzheimer’s disease-associated phenotypes using a novel 3D blood-brain barrier neurosphere co-culture modelEC Ko, S Spitz, FM Pramotton, OM Barr, C Xu, G Pavlou, S Zhang, A Tsai, ...Frontiers in Bioengineering and Biotechnology 11, 1251195, 202342023
3-)
Mitigation of Equine Recurrent Uveitis through Topical Suppressor of Cytokine Signaling-1 (SOCS1) Mimetic Peptide: Open Label Safety and Efficacy Pilot StudyJ Larkin, T Polk, J Sharma, S Bae, O Barr, A Jones, H Kitchen, M Wihelmy, ...The Journal of Immunology 204 (1_Supplement), 92.43-92.43, 202022020
4-)
Mitigation of Equine Recurrent Uveitis Through Topical Suppressor of Cytokine Signaling-1 Mimetic Peptide: Open Label Safety and Efficacy Pilot StudyCE Plummer, T Polk, J Sharma, S Bae, O Barr, A Jones, H Kitchen, ...12022
5-)
Engineered 3D human neurovascular model of Alzheimer’s disease to study vascular dysfunctionG Pavlou, S Spitz, FM Pramotton, A Tsai, BM Li, X Wang, OM Barr, EC Ko, ...Biomaterials, 122864, 20242024
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept